Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
-858K
-
Total reported value, excl. options
-
$303M
-
Value change
-
-$33.6M
-
Put/Call ratio
-
0.01
-
Number of buys
-
43
-
Number of sells
-
-40
-
Price
-
$14.92
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2014
104 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2014.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 49.8M outstanding shares and own 40.78% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6.06M shares), VANGUARD GROUP INC (1.49M shares), FIRST MANHATTAN CO (1.45M shares), BlackRock Fund Advisors (1.2M shares), OPPENHEIMER FUNDS INC (1.09M shares), State Street Corp (960K shares), Foundation Asset Management, LP (934K shares), BlackRock Institutional Trust Company, N.A. (728K shares), D. E. Shaw & Co., Inc. (641K shares), and ROYCE & ASSOCIATES LLC (574K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.